You are here

GSK

GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B

BioSpace

Fri, 05/17/24 - 11:47 am

consumer health

Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline

Fierce Biotech

Mon, 05/13/24 - 11:25 am

Fulcrum Therapeutics

clinical trials

Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap

Xtalks

Tue, 05/7/24 - 06:29 pm

GSK defends itself—again—after senator argues it withdrew popular asthma med to dodge price caps and Medicaid rebates

Fierce Pharma

Fri, 05/3/24 - 11:26 am

FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta

Medical Marketing and Media

Fri, 05/3/24 - 11:10 am

Trelegy Ellipta

GSK's Arexvy maintains its RSV market dominance, looks to key label expansion as Moderna's mRNA threat looms

Fierce Pharma

Wed, 05/1/24 - 11:07 pm

GSK raises profit outlook on strong vaccine, HIV drug sales

Reuters

Wed, 05/1/24 - 11:01 am

Genomics and GSK to integrate polygenic risk scores into trials

Clinical Trials Arena

Wed, 05/1/24 - 11:00 am

clinical trials

Pfizer takes top spot in docs' vaccine ranking by 'huge margin'

Fierce Pharma

Wed, 05/1/24 - 09:35 am

Moderna Therapeutics

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

Reuters

Thu, 04/25/24 - 11:40 am

CureVac initiates H5N1 avian influenza vaccine study

Clinical Trials Arena

Thu, 04/25/24 - 11:35 am

clinical trials

GSK reports positive data from Phase III gonorrhoea antibiotic trial

Clinical Trials Arena

Thu, 04/18/24 - 11:06 am

GSK says efficacy of its shingles vaccine remains high after years

Reuters

Wed, 04/17/24 - 10:06 pm

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

Pharmaphorum

Tue, 04/16/24 - 07:35 am

meningococcal disease

GSK’s Maya Martinez David: ‘Trust is the most powerful thing in an organization’

Biopharma Reporter

Wed, 03/27/24 - 10:54 am

Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice

Fierce Pharma

Tue, 03/26/24 - 04:26 pm

Bristol Myers Squibb

A year after the acquisition of Bellus Health, GSK planning to let go of most former Bellus employees

LinkedIn

Fri, 03/22/24 - 10:50 am

GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month

Fierce Pharma

Thu, 03/21/24 - 06:37 pm

Boehringer Ingelheim

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data

BioSpace

Mon, 03/18/24 - 05:11 pm

endometrial cancer

GSK Advances Blenrep’s Potential Comeback with Second Phase III Win

BioSpace

Thu, 03/7/24 - 05:32 pm

antibody-drug conjugate

Pages